Search
for
Sort by
Research 181–210 of 1000+
- Alopecia areata in 2 patients treated with dupilumab: New onset and worsening
- Treatment of severe alopecia areata with baricitinib
- Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes
- Drug repositioning using <i>in silico</i> compound profiling
- Combination tofacitinib and oral minoxidil treatment for severe alopecia areata
- Hypertrichosis of vellus hairs of the malar region after unilateral treatment with bimatoprost
- Validation of the Alopecia Areata Patient Priority Outcomes (AAPPO) Questionnaire in Adults and Adolescents with Alopecia Areata
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations
- Contraception and the dermatologist
- Minoxidil: a comprehensive review
- Treatment of male and female pattern hair loss with sublingual minoxidil: a retrospective case‐series of 64 patients
- Safety of oral bicalutamide in female pattern hair loss: A retrospective review of 316 patients
- Hypertrichosis of vellus hairs of the malar region after unilateral treatment with bimatoprost
- (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile, a potent androgen receptor antagonist for stimulating hair growth and reducing sebum production
- Economic Burden and Healthcare Resource Use of Alopecia Areata in an Insured Population in the USA
- Mild-to-moderate COVID-19 is not associated with worsening of alopecia areata: A retrospective analysis of 32 patients
- Response of alopecia areata of the beard to oral tofacitinib
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Chemical pharmacotherapy options for managing adult acne
- Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics
- Low-dose oral minoxidil for treating alopecia: A 3-year North American retrospective case series
- Novel therapies for alopecia areata: The era of rational drug development
- Hair Transplantation for Men and Women
- Treatment Patterns and Treatment Satisfaction Among Adults with Alopecia Areata in the United States
- Clinicopathological characteristics and treatment outcomes of fibrosing alopecia in a pattern distribution: A retrospective cohort study
- Dermoscopy of an osteonevus of Nanta
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
- Estimation of health utility values for alopecia areata
- Intraethnic variation in steroid-5-alpha-reductase polymorphisms in prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment